EP2279254
NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY
Anmelder
PROTIVA BIOTHERAPEUTICS INC [CA]
Erfinder
MACLACHLAN IAN [CA]YAWORSKI EDWARD [CA]LAM KIEU [CA]JEFFS LLOYD B [CA]PALMER LORNE R [CA]
Externe Quellen
Klassifikation
IPC-Klassen
A61K 31/712A61K 31/713A61K 9/127A61P 35/00C12N 15/11C12N 15/113C12N 15/88A61K 47/48
CPC-Klassen
A61K 31/713A61K 48/0025A61K 9/1271A61K 9/1272A61P 1/16A61P 31/12A61P 31/14A61P 35/00C07H 21/00C07J 9/00C12N 15/111C12N 15/113C12N 15/1137
AI: Life Sciences
warum
Protiva lipid-nanoparticle therapeutics — A61K + A61P35 + C12N15. Life Science.